Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytek Biosciences (CTKB) Accounts Payables (2020 - 2026)

Cytek Biosciences filings provide 6 years of Accounts Payables readings, the most recent being $6.4 million for Q4 2025.

  • On a quarterly basis, Accounts Payables rose 15.93% to $6.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.4 million, a 15.93% increase, with the full-year FY2025 number at $6.4 million, up 15.93% from a year prior.
  • Accounts Payables hit $6.4 million in Q4 2025 for Cytek Biosciences, down from $7.6 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $7.6 million in Q3 2025 to a low of $3.0 million in Q4 2023.
  • Median Accounts Payables over the past 5 years was $5.3 million (2023), compared with a mean of $5.0 million.
  • Biggest five-year swings in Accounts Payables: crashed 54.33% in 2023 and later surged 114.76% in 2025.
  • Cytek Biosciences' Accounts Payables stood at $3.0 million in 2021, then soared by 58.37% to $4.8 million in 2022, then crashed by 36.9% to $3.0 million in 2023, then skyrocketed by 82.35% to $5.5 million in 2024, then rose by 15.93% to $6.4 million in 2025.
  • The last three reported values for Accounts Payables were $6.4 million (Q4 2025), $7.6 million (Q3 2025), and $6.9 million (Q2 2025) per Business Quant data.